Most people find their optimal dose somewhere between 4mg and 12mg weekly, depending on individual response and goals
Thresholds derived from Phase 2 dose-response data and tissue-specific glucagon receptor pharmacology
Lipoprotein (a) is not associated with lifestyle factors but is considered to have additive ASCVD risk to BMI [17]
This is why preserving lean mass during weight loss is so important, especially when using potent weight-loss medications
Memorandum number 202317020
JACC 84(17):16151628 Wallner M, Biber ME, Stolfo D, Sinagra G, Benson L, Dahlstrm U et al (2024) Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries